Leapfrog Bio
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10 Stuart St, Kingston, Ontario, K7L 2V5...Website
leapfrog.bioRevenue
<$5 MillionIndustry
About Leapfrog Bio
Leapfrog Bio is focused on developing targeted therapies for cancers driven by genetic mutations that are resistant to conventional treatments. Utilizing their proprietary OncoSLX platform, they identify and target hidden genetic vulnerabilities in cancers, particularly those caused by loss-of-function mutations. Their lead product candidate, LFB190, is a promising BET inhibitor aimed at treating cancers with EP300 mutations, addressing significant unmet clinical needs. The company aims to improve patient outcomes by accelerating drug development and reducing translational risks through their innovative approach.Explore more
Leapfrog Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Leapfrog Bio
Compare insights from companies similar to Leapfrog Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Leapfrog Bio Tech Stack
A closer look at the technologies used by Leapfrog Bio
See more technologies
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Leapfrog Bio
Sign Up For FreeTo access detailed company insights
Leapfrog Bio is focused on developing targeted therapies for cancers driven by genetic mutations that are resistant to conventional treatments. Utilizing their proprietary OncoSLX platform, they identify and target hidden genetic vulnerabilities in cancers, particularly those caused by loss-of-function mutations. Their lead product candidate, LFB19... Read More
